Merck Pre-Tax Income 2010-2024 | MRK

Merck pre-tax income for the twelve months ending September 30, 2024 was $13.720B, a 84.21% increase year-over-year.

  • Merck annual pre-tax income for 2023 was $1.889B, a 88.51% decline from 2022.
  • Merck annual pre-tax income for 2022 was $16.444B, a 18.48% increase from 2021.
  • Merck annual pre-tax income for 2021 was $13.879B, a 136.72% increase from 2020.

Merck Pre-Tax Income 2010-2024 | MRK

  • Merck annual pre-tax income for 2023 was $1.889B, a 88.51% decline from 2022.
  • Merck annual pre-tax income for 2022 was $16.444B, a 18.48% increase from 2021.
  • Merck annual pre-tax income for 2021 was $13.879B, a 136.72% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Novo Nordisk (NVO)$483B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$354.3B
Novartis AG (NVS)$218.9B
AstraZeneca (AZN)$200.6B
Pfizer (PFE)$155.6B
Sanofi (SNY)$131.3B
Innoviva (INVA)$1.3B